Evidence map›Paper›PMID 23670673›Full record

ArticleClinical orthopaedics and related research2013

Percutaneous doxycycline treatment of aneurysmal bone cysts with low recurrence rate: a preliminary report.

William E Shiels, Joel L Mayerson

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Clinical orthopaedics and related research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05696834 (Sclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone Cyst), which is not on this map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05696834 unknown statusnot on this mapstarted 2023, after this paper: background citation

Sclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone Cyst

TypeobservationalSponsorAl-Azhar UniversityRan2023 to 2025Enrolled20ConditionsOrthopedic DisorderArmsSclerotherapy With Adjuvant Bone Marrow Injection In Management of Aneurysmal Bone Cyst
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 140 citations in OpenAlex.

  1. Percutaneous treatments of primary aneurysmal bone cysts: systematic review and meta-analysis.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2021
    Pooled it
  2. Spinal aneurysmal bone cysts in children - institutional chart review and recommendation for treatment.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  3. Review
  4. Article
  5. Management of spinal aneurysmal bone cyst: A case report.Surgical neurology international · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Cystic bone Lesions: Diagnostic pitfalls and therapeutic considerations.Journal of clinical orthopaedics and trauma · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

William E ShielsDepartment of Radiology, The Ohio State University Medical Center and Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA. william.shiels@nationwidechildrens.org
Joel L Mayerson
The Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAneurysmal bone cyst (ABC) has a recurrence rate of between 12% and 71% without en bloc resection or amputation. There is no percutaneous ABC treatment drug regimen demonstrating consistent evidence of bone healing with recurrence of < 12%. Doxycycline has properties that may make it appropriate for percutaneous treatment. QUESTIONS/PURPOSES: We therefore asked: (1) Is there reduction in ABC lytic cyst volume with injectable doxycycline? (2) Is it associated with thickening of involved bony cortex? (3) Is the recurrence rate after percutaneous treatment < 12%?

methodsWe retrospectively reviewed 20 patients who underwent percutaneous treatment of ABCs with doxycycline from 2006 to 2010. The mean age was 10 years (range, 3-18 years). There were 21 treatment locations: humerus (six), spine (five), clavicle (two), fibula (one), femur (two), ulna (two), tibia (two), and scapula (one). Twenty patients completed treatment involving 118 treatment sessions (two to 14 sessions per patient). Treatment response was evaluated radiographically by measuring the lytic component and thickness of involved cortex. Recurrence was indicated by new areas of lytic destruction after completion of treatment. The minimum followup was 24 months (mean, 38 months).

resultsTwenty of 20 patients demonstrated reduction in lytic destruction and bony healing. All patients demonstrated cortical thickening. One patient demonstrated recurrent minimal lytic destruction after 20 months of observation.

conclusionsIn this series, patients undergoing percutaneous doxycycline treatment of ABCs demonstrated a healing response and a recurrence rate of 5% at more than 24 months.

Indexed as

AdolescentBone Cysts, AneurysmalChildChild, PreschoolDoxycyclineHumansInjections, IntralesionalMagnetic Resonance ImagingRecurrenceRetrospective StudiesTime FactorsTreatment OutcomeDoxycycline

Identifiers

PMID23670673
PMCPMC3705068
OpenAlexW2048019121

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.